Clinical Trials Browser

Phase 3 × Squamous Cell Carcinoma of Head and Neck × Capecitabine × Clear all

NCT05044117 2022-03-03

Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck